BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 34255086)

  • 1. Longitudinal Changes in Cognitive Function in a Nationwide Cohort Study of Patients With Lymphoma Treated With Chemotherapy.
    Janelsins MC; Mohamed M; Peppone LJ; Magnuson A; Belcher EK; Melnik M; Dakhil S; Geer J; Kamen C; Minasian L; Reagan PM; Mohile SG; Morrow GR; Ahles TA; Heckler CE
    J Natl Cancer Inst; 2022 Jan; 114(1):47-59. PubMed ID: 34255086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Longitudinal Trajectory and Characterization of Cancer-Related Cognitive Impairment in a Nationwide Cohort Study.
    Janelsins MC; Heckler CE; Peppone LJ; Ahles TA; Mohile SG; Mustian KM; Palesh O; O'Mara AM; Minasian LM; Williams AM; Magnuson A; Geer J; Dakhil SR; Hopkins JO; Morrow GR
    J Clin Oncol; 2018 Sep; 36(32):JCO2018786624. PubMed ID: 30240328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognitive Complaints in Survivors of Breast Cancer After Chemotherapy Compared With Age-Matched Controls: An Analysis From a Nationwide, Multicenter, Prospective Longitudinal Study.
    Janelsins MC; Heckler CE; Peppone LJ; Kamen C; Mustian KM; Mohile SG; Magnuson A; Kleckner IR; Guido JJ; Young KL; Conlin AK; Weiselberg LR; Mitchell JW; Ambrosone CA; Ahles TA; Morrow GR
    J Clin Oncol; 2017 Feb; 35(5):506-514. PubMed ID: 28029304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Longitudinal Relationship Between Frailty and Cognition in Patients 50 Years and Older with Breast Cancer.
    Magnuson A; Lei L; Gilmore N; Kleckner AS; Lin FV; Ferguson R; Hurria A; Wittink MN; Esparaz BT; Giguere JK; Misleh J; Bautista J; Mohile SG; Janelsins MC
    J Am Geriatr Soc; 2019 May; 67(5):928-936. PubMed ID: 31034595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perceived cognitive impairment in people with colorectal cancer who do and do not receive chemotherapy.
    Dhillon HM; Tannock IF; Pond GR; Renton C; Rourke SB; Vardy JL
    J Cancer Surviv; 2018 Apr; 12(2):178-185. PubMed ID: 29080061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physical Activity Patterns and Relationships With Cognitive Function in Patients With Breast Cancer Before, During, and After Chemotherapy in a Prospective, Nationwide Study.
    Salerno EA; Culakova E; Kleckner AS; Heckler CE; Lin PJ; Matthews CE; Conlin A; Weiselberg L; Mitchell J; Mustian KM; Janelsins MC
    J Clin Oncol; 2021 Oct; 39(29):3283-3292. PubMed ID: 34406822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer-related cognitive impairment and wellbeing in patients with newly diagnosed aggressive lymphoma compared to population norms and healthy controls: an exploratory study.
    Gates P; Dhillon HM; Krishnasamy M; Wilson C; Gough K
    Support Care Cancer; 2024 Mar; 32(4):238. PubMed ID: 38512692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cognitive rehabilitation program to improve cognition of cancer patients treated with chemotherapy: A 3-arm randomized trial.
    Dos Santos M; Hardy-Léger I; Rigal O; Licaj I; Dauchy S; Levy C; Noal S; Segura C; Delcambre C; Allouache D; Parzy A; Barriere J; Petit T; Lange M; Capel A; Clarisse B; Grellard JM; Lefel J; Joly F
    Cancer; 2020 Dec; 126(24):5328-5336. PubMed ID: 32996583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fatigue, anxiety, and quality of life in breast cancer patients compared to non-cancer controls: a nationwide longitudinal analysis.
    Williams AM; Khan CP; Heckler CE; Barton DL; Ontko M; Geer J; Kleckner AS; Dakhil S; Mitchell J; Mustian KM; Peppone LJ; Kipnis V; Kamen CS; O'Mara AM; Janelsins MC
    Breast Cancer Res Treat; 2021 May; 187(1):275-285. PubMed ID: 33392843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive complaints after breast cancer treatments: examining the relationship with neuropsychological test performance.
    Ganz PA; Kwan L; Castellon SA; Oppenheim A; Bower JE; Silverman DH; Cole SW; Irwin MR; Ancoli-Israel S; Belin TR
    J Natl Cancer Inst; 2013 Jun; 105(11):791-801. PubMed ID: 23606729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterogeneous Response of Chemotherapy-Related Cognitive Decline in Patients with Breast Cancer: A Prospective Study.
    Schrauwen W; Van de Cavey J; Vingerhoets G; Vanheule S; Van den Broecke R; Denys H
    J Int Neuropsychol Soc; 2020 Sep; 26(8):806-814. PubMed ID: 32312360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Motoric cognitive risk syndrome is associated with processing speed and executive function, but not delayed free recall memory: The Korean frailty and aging cohort study (KFACS).
    Shim H; Kim M; Won CW
    Arch Gerontol Geriatr; 2020; 87():103990. PubMed ID: 31786409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive effects of adjuvant endocrine therapy in older women treated for early-stage breast cancer: a 1-year longitudinal study.
    Underwood EA; Jerzak KJ; Lebovic G; Rochon PA; Elser C; Pritchard KI; Tierney MC
    Support Care Cancer; 2019 Aug; 27(8):3035-3043. PubMed ID: 30610433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluating cognitive complaints in breast cancer survivors with the FACT-Cog and quantitative electroencephalography.
    Van Dyk K; Hunter AM; Ercoli L; Petersen L; Leuchter AF; Ganz PA
    Breast Cancer Res Treat; 2017 Nov; 166(1):157-166. PubMed ID: 28707203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of Unruptured Intracranial Aneurysms and Cognitive Performance: Preliminary Results of a Prospective Clinical Trial.
    Bründl E; Böhm C; Lürding R; Schödel P; Bele S; Hochreiter A; Scheitzach J; Zeman F; Brawanski A; Schebesch KM
    World Neurosurg; 2016 Oct; 94():145-156. PubMed ID: 27392894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prechemotherapy Levels of Plasma Dehydroepiandrosterone and Its Sulfated Form as Predictors of Cancer-Related Cognitive Impairment in Patients with Breast Cancer Receiving Chemotherapy.
    Toh YL; Shariq Mujtaba J; Bansal S; Yeo A; Shwe M; Lau AJ; Chan A
    Pharmacotherapy; 2019 May; 39(5):553-563. PubMed ID: 30892712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benzodiazepine Use Disorder and Cognitive Impairment in Older Patients: A Six-Month-Follow-Up Study in an Outpatient Unit in Barcelona.
    Ros-Cucurull E; Palma-Álvarez RF; García-Raboso E; Cardona-Rubira C; Jacas C; Grau-López L; Robles-Martínez M; Daigre C; Ros-Montalbán S; Casas M; Ramos-Quiroga JA; Roncero C
    J Stud Alcohol Drugs; 2018 Nov; 79(6):844-852. PubMed ID: 30573014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase III Randomized, Placebo-Controlled Clinical Trial of Donepezil for Treatment of Cognitive Impairment in Breast Cancer Survivors After Adjuvant Chemotherapy (WF-97116).
    Rapp SR; Dressler EV; Brown WM; Wade JL; Le-Lindqwister N; King D; Rowland KM; Weaver KE; Klepin HD; Shaw EG; Lesser GJ
    J Clin Oncol; 2024 May; ():JCO2301100. PubMed ID: 38709986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psychometric Evaluation of the Neuropsychological Test Battery in Individuals with Normal Cognition, Mild Cognitive Impairment, or Mild to Moderate Alzheimer's Disease: Results from a Longitudinal Study.
    Harrison JE; Rentz DM; Brashear HR; Arrighi HM; Ropacki MT; Liu E
    J Prev Alzheimers Dis; 2018; 5(4):236-244. PubMed ID: 30298182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.